Fig 1.
Schedule of enrolment, interventions, and assessments.
Notes: CAP, controlled attenuation parameter; FFA, free fatty acid; LSM, liver stiffness measurement; NFS, Nonalcoholic fatty liver fibrosis score; FIB-4, Fibrosis 4 score; HOMA-IR, Homeostatic model assessment for insulin resistance.
Fig 2.
Notes: T2DM, type 2 diabetes mellitus; NAFLD, nonalcoholic fatty liver disease; CAP, controlled attenuation parameter; LSM, liver stiffness measurement.